Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX: JWEL) today reported its second quarter results for the period ended June 30, 2026. All amounts are expressed in Canadian dollars ("CAD"). Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See "Non-IFRS and Other Financial Measures" below.

Management Commentary

"Q2 was another strong quarter for Jamieson Wellness, with revenue growth of nearly 19% across our brands and contributions from all of our key markets," said Mike Pilato, President and CEO of Jamieson Wellness. "A successful 6/18 campaign in China, continued innovation and strong consumer demand supported our results through the quarter, contributing to 17% growth across our branded business in the first half of 2026.

"As announced this afternoon, we have entered into an agreement to be acquired by Kirin Holdings Company, Limited ("Kirin"). We believe the transaction reflects the strength of the business our team has built and the value of our portfolio, and I would like to thank our team members for their ongoing dedication to serving our consumers, customers and partners."

Second Quarter Highlights

Second Quarter Financial Results Consolidated Summary

All comparisons are with the second quarter of 2025

Summary of Segment Results

All comparisons are with the second quarter of 2025 and reflect the allocation of youtheory brand revenue to its respective branded business segment.

Jamieson Brands

Strategic Partners

Balance Sheet and Cash Flow from Operations

All comparisons are with the second quarter of 2025

Withdrawal of Financial Guidance for Fiscal 2026

In light of the earlier announcement today of the Company entering into a definitive arrangement agreement (the "Arrangement Agreement") with Kirin, pursuant to which Kirin has agreed to acquire all of the issued and outstanding common shares (the "Shares") of the Company (the "Transaction") at a price of CAD $45.75 per Share in cash, the Company is withdrawing its previously issued financial guidance for the 2026 fiscal year. 

The announced Transaction represents a significant strategic shift that will impact the Company's capital structure and financial profile. Due to the inherent unpredictability of the precise timing of the closing, transaction-related expenses, integration costs and the ultimate financial impact of the Transaction, management believes it is prudent to withdraw its outlook at this time. 

Declaration of Second Quarter Dividend

The Board of Directors of the Company authorized a 2.0 cent or an 8.7% increase in the quarterly dividend and declared a cash dividend for the second quarter of 2026:

Consolidated Financial Statements and Management's Discussion and Analysis

The Company's unaudited condensed consolidated interim financial statements and accompanying notes as at and for the three and six months ended June 30, 2026 and related MD&A are available under the Company's profile on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company's website at https://investors.jamiesonwellness.com.

Conference CallAs noted earlier today, in light of the recently announced Transaction, the regularly scheduled conference call to discuss the Company's second quarter 2026 results has been cancelled. 

About Jamieson Wellness  

Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements ("VMS") brand. The Company's youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information, please visit jamiesonwellness.com.

Jamieson Wellness' head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada.

Forward-Looking Information

This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to statements regarding the Transaction, including the proposed timing and completion of the Transaction,. Words such as "expect", "anticipate", "intend", "may", "will", "estimate" and variations of such words and similar expressions are intended to identify such forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances, which could prove to be incorrect.

The forward-looking information in this press release is based on a number of assumptions, including our ability to complete the Transaction on the terms and conditions contemplated, or on the timing, currently contemplated.  The forward-looking information in this press release is also subject to a number of risks and uncertainties, many of which are beyond the Company's control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include the factors discussed under "Risk Factors" in the Company's Annual Information Form dated March 31, 2026 and under the "Risk Factors" section in the MD&A filed today, August 6, 2026. The Company cautions that the forgoing list of assumptions and risks is not exhaustive and other factors could also adversely affect the Company's results.

The forward-looking information in this press release is given as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Non-IFRS and Other Financial Measures

This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and to analyze the Company's business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS. The Company uses the following non-IFRS financial measures: "EBITDA", "Adjusted EBITDA" and "Adjusted net earnings", the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, "normalized gross profit", "normalized SG&A", "normalized earnings from operations", "cash from operating activities before working capital considerations" and "net debt", the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: "Adjusted EBITDA margin", "Adjusted diluted earnings per share", "normalized gross profit margin", "normalized operating margin", and the following supplementary financial measures: "gross profit margin" and "operating margin" to provide supplemental measures of the Company's operating performance and thus highlight trends in the Company's core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the "How we Assess the Performance of our Business" section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company's financial statements to which the measure relates.

The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the "Non-IFRS and Other Financial Measures" of this press release for further information on each non-IFRS financial measure) for the three and six months ended June 30, 2026.

SOURCE Jamieson Wellness Inc.

SOURCE: Jamieson Wellness Inc.

Investor Relations and Media Contact Information:AJamieson Wellness, Ruth Winker,
416-960-0052, rwinker@jamiesonlabs.com

COMTEX_490201366/2197/2026-08-06T17:08:00